Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Laryngeal Disease”

1,085 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,085 results

Not applicableUnknownNCT06086119
What this trial is testing

Quality of Life and Voice Perception in Patients Laryngoctomized Phonatory Wearers

Who this might be right for
Quality of LifeLarynx Cancer
Regina Elena Cancer Institute 31
Not applicableEnded earlyNCT02493491
What this trial is testing

Neurogenic Dysphonia/Dysphagia Registry

Who this might be right for
Neurogenic DysphoniaNeurogenic Dysphagia
Merz North America, Inc. 146
Testing effectiveness (Phase 2)Ended earlyNCT01313390
What this trial is testing

Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University College, London 4
Testing effectiveness (Phase 2)Study completedNCT00101348
What this trial is testing

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more
National Cancer Institute (NCI) 66
Not applicableUnknownNCT00983697
What this trial is testing

FDG-PET/CT in Assessing the Tumor and Planning Neck Surgery in Patients With Newly Diagnosed H&N Cancer

Who this might be right for
Head and Neck Cancer
American College of Radiology Imaging Network 292
Post-approval studies (Phase 4)Study completedNCT04839276
What this trial is testing

Administration of Platelet-rich Fibrin to Autologous Fat Tissue in Injection Laryngoplasty for Vocal Cord Paralysis

Who this might be right for
Vocal Cord Paralysis
Fakultas Kedokteran Universitas Indonesia 19
Not applicableStudy completedNCT01659268
What this trial is testing

Performance of Baccalaureate Nursing Students in Insertion of Laryngeal Mask: a Trial in Mannequins

Who this might be right for
Respiratory Failure
University of Sao Paulo 17
Not applicableStudy completedNCT03368599
What this trial is testing

Endobronchial Intubation of Double-lumen Tube: Conventional Method vs Fiberoptic Bronchoscope Guide Method

Who this might be right for
Intubation, IntratrachealPostoperative ComplicationsSore Throat+3 more
Seoul National University Bundang Hospital 136
Testing effectiveness (Phase 2)Ended earlyNCT05551117
What this trial is testing

Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors

Who this might be right for
Castration-Resistant Prostatic CancerAndrogen-Independent Prostatic CancerAndrogen-Insensitive Prostatic Cancer+14 more
MacroGenics 192
Not applicableUnknownNCT03543150
What this trial is testing

BOTOX® Drug Use Investigation (Spasmodic Dysphonia)

Who this might be right for
Dysphonia
GlaxoSmithKline 400
Not applicableUnknownNCT03528590
What this trial is testing

Ventilation Efficacy of Size 3 or Size 4 I-gel in Female Patient Weighing 50 to 60 Kilograms

Who this might be right for
Body WeightBreast NeoplasmsLaryngeal Masks
National Taiwan University Hospital 98
Not applicableStudy completedNCT01257633
What this trial is testing

Surgical Treatment of Early Stage Glotto-supraglottic Laryngeal Cancer Via Transoral Resection With Robotic Assistance

Who this might be right for
Laryngeal Neoplasms
Centre Hospitalier Universitaire de Nīmes 54
Not applicableStudy completedNCT00002520
What this trial is testing

Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Eastern Cooperative Oncology Group 434
Large-scale testing (Phase 3)WithdrawnNCT04129320
What this trial is testing

Enoblituzumab Plus MGA012 or MGD013 in Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck CancerSquamous Cell Carcinoma of Head and Neck
MacroGenics
Not applicableStudy completedNCT01118533
What this trial is testing

Impact of Blades Used for Scheduled Orotracheal Intubation on Postoperative Sore Throat

Who this might be right for
Tracheal Intubation MorbiditySore Throat
Assistance Publique - Hôpitaux de Paris 712
Not applicableStudy completedNCT01854970
What this trial is testing

Benefit of Pharyngeal and Oesophageal pH-impedance of Patients With High Suspicion of Laryngopharyngeal Reflux

Who this might be right for
Laryngopharyngeal RefluxOesophageal pH-impedance
University Hospital, Bordeaux 30
Not applicableStudy completedNCT01843673
What this trial is testing

Image-Guided Adaptive Radiotherapy for in Detecting Tumors During Treatment in Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Virginia Commonwealth University 16
Early research (Phase 1)Study completedNCT00066651
What this trial is testing

Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors

Who this might be right for
Cervical CancerFallopian Tube CancerHead and Neck Cancer+5 more
National Cancer Institute (NCI)
Not applicableStudy completedNCT04437394
What this trial is testing

Evaluation of Functions of Swallowing and Voice in Ankylosing Spondylitis Patients

Who this might be right for
Ankylosing SpondylitisSwallowing Disorder.Other SpecifiedVoice Alteration
Yavuz Atar 60
Large-scale testing (Phase 3)Looking for participantsNCT06295731
What this trial is testing

INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Inhibrx Biosciences, Inc 410
Load More Results